754
Participants
Start Date
November 30, 2012
Primary Completion Date
October 31, 2013
Study Completion Date
November 30, 2013
Zirconium silicate (acute phase)
Randomized oral doses (1.25g, 2.5g, 5g, and 10g) of microporous, fractionated, protonated zirconium silicate administered 3 times (tid) daily with meals for 48 hours.
Zirconium silicate (subacute phase)
Randomized oral doses (1.25g, 2.5g, 5g, and 10g) of microporous, fractionated, protonated zirconium silicate administered once a day prior to the morning meal for 12 days.
Placebo (acute phase)
Randomized to mimic doses of experimental drug administered 3 times (tid) daily with meals for 48 hours during the acute phase.
Placebo ( subacute phase)
Randomized to mimic doses of experimental drug administered once a day prior to the morning meal for 12 days during the subacute phase.
Life Medi-Research and Management, Brooklyn
United Medical Associates, Binghamton
Doylestown Hospital Medical Research, Doylestown
Washington Nephrology Associates, Bethesda
South Carolina Nephrology & Hypertension, Orangeburg
Carolina Diabetes and Kidney Center, Sumter
Riverside Clinical Research, Edgewater
PCCC of Volusia, New Smyrna Beach
Endocrinology of Central Florida, Lake Mary
San Marcus Research Clinic, Miami
Prevention & Strengthening Solutions, Inc, Miramar
Medical Consulting Center, Miami
Elite Research Institute, Miami
Metabolic Research Institute, West Palm Beach
JEM Research Institute, Atlantis
Clinical Research of Brandon, Brandon
Clinical Research Trials of Florida, Tampa
Meridien Research, St. Petersburg
Meridien Research, Lakeland
Lakeview Medical Research, Summerfield
Meridien Research, Brooksville
Saadat Ansari Internal Medicine, Huntsville
Pinnacle Research Group, Anniston
The Center for Clinical Trials, Biloxi
Nephrology Center DBA, Paragon Health PC, Kalamazoo
Research by Design, Evergreen Park
Clinical Research Consultants, LLC, Kansas City
Professional Research Network of Kansas, LLC, Wichita
Southwest Houston Research, Ltd, Houston
Clinical Advancement Center, PLLC, San Antonio
Denver Nephrologists, PC, Denver
Pikes Peak Nephrology Associates, Colorado Springs
Southern Utah Kidney and Hypertension Center, St. George
Southwest Clinical Research Institute, Tempe
Aspire Clinical Studies, LLC, Glendale
Academic Medical Research Institute, Los Angeles
Torrance Clinical Research, Lomita
Mohammad Ismail, Inc, Paramount
California Institute of Renal Research, Chula Vista
Apex Research of Riverside, Riverside
Capital Nephrology Clinical Group, Sacramento
Nephrology and Hypertension Associates, Middlebury
Renal Research, Gosford
Melbourne Renal Research Group, Reservoir
ZS Pharma, Inc.
INDUSTRY